HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CPSC

This article was originally published in The Rose Sheet

Executive Summary

Nomination of Mary Sheila Gall as chair of Consumer Products Safety Commission opposed by Senate Commerce Committee Democrats Aug. 2. Nomination was rejected in split vote down party lines; Democrats hold a 12-11 majority. During July 25 hearing, several majority members questioned Gall's commitment to consumer safety, suggesting her industry-friendly voting record goes against CPSC's mission. "Mary Gall did not lose today, bipartisanship lost today," Bush Administration Press Secretary Ari Fleischer said in an Aug. 2 statement. "Many of the same Senators who voted for Mary Gall when she was nominated by President Clinton just two years ago, voted against her today demonstrating the purely partisan nature of this vote." The Administration could still push for a vote on the Senate floor, although Senate Majority Leader Tom Daschle (S.D.) has said he will not allow such an action. Gall has served as one of three CPSC commissioners since December 1991

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009487

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel